Conditionnements
| Conditionnement | Code | Statut |
|---|---|---|
| SIMVASTATIN 20MG; SITAGLIPTIN PHOSPHATE EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | NDA202343-005 | Discontinued |
| SIMVASTATIN 40MG; SITAGLIPTIN PHOSPHATE EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | NDA202343-003 | Discontinued |
| SIMVASTATIN 10MG; SITAGLIPTIN PHOSPHATE EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | NDA202343-001 | Discontinued |
| SIMVASTATIN 40MG; SITAGLIPTIN PHOSPHATE EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | NDA202343-006 | Discontinued |
| SIMVASTATIN 10MG; SITAGLIPTIN PHOSPHATE EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | NDA202343-004 | Discontinued |
| SIMVASTATIN 20MG; SITAGLIPTIN PHOSPHATE EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | NDA202343-002 | Discontinued |
Documents
Les textes officiels, sur le site de l’autorité.